COVID‐19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"COVID‐19 Vaccination for People With Autoimmune Inflammatory Rheumatic Diseases On Immunomodulatory Therapies." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431669/all/COVID‐19_vaccination_for_people_with_autoimmune_inflammatory_rheumatic_diseases_on_immunomodulatory_therapies.
COVID‐19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431669/all/COVID‐19_vaccination_for_people_with_autoimmune_inflammatory_rheumatic_diseases_on_immunomodulatory_therapies. Accessed January 15, 2025.
COVID‐19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431669/all/COVID‐19_vaccination_for_people_with_autoimmune_inflammatory_rheumatic_diseases_on_immunomodulatory_therapies
COVID‐19 Vaccination for People With Autoimmune Inflammatory Rheumatic Diseases On Immunomodulatory Therapies [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431669/all/COVID‐19_vaccination_for_people_with_autoimmune_inflammatory_rheumatic_diseases_on_immunomodulatory_therapies.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - COVID‐19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies
ID - 431669
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431669/all/COVID‐19_vaccination_for_people_with_autoimmune_inflammatory_rheumatic_diseases_on_immunomodulatory_therapies
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -